NCT06508723

Brief Summary

This controlled, parallel clinical study aims to compare the effect of fixed prosthetic restorations placed in the posterior region with different implant surfaces on clinical and peri-implant marginal bone loss. The main question(s) it aims to answer are: Is there a difference between peri-implant marginal bone loss levels in dental implants with two different surfaces placed in the posterior region? Is there a difference in peri-implant clinical parameters in dental implants with two different surfaces placed in the posterior region? The study includes a test group (implant with Ti-Ulta surface) and a control group (implant with Ti-Unite surface). Two implants with different surfaces will be placed in the bone following the same routine implant placement protocol.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 5, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

July 15, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 18, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 5, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 5, 2025

Completed
Last Updated

December 2, 2024

Status Verified

November 1, 2024

Enrollment Period

2.4 years

First QC Date

July 15, 2024

Last Update Submit

November 27, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Peri-implant marginal bone loss

    The primary outcome was the assessment of marginal bone loss on radiographs at 1-year follow-up.

    1-year follow-up of all implants after prosthetic loading

Study Arms (2)

Test Group

OTHER

The group in which implants with a Ti-Ultra surface are placed.

Procedure: Dental implant placement

Control Group

OTHER

The group in which implants with a Ti-Unite surface are placed.

Procedure: Dental implant placement

Interventions

The same routine implant placement protocol will be applied to both study groups with different surfaces and will be placed in the bone. After local anesthesia, a full-thickness flap will be raised. The implant socket will be created according to the protocol recommended by the company and all implants will be placed in the socket with a torque force of 35 N and the implants will be placed. Once bleeding control is achieved, the flap will be closed primarily. Healing caps will be installed after 3 months. After waiting for wound healing, prosthetic restoration will be performed.

Control GroupTest Group

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Please find below the revised text which is clearer and free of any spelling, grammar or punctuation errors:
  • The patient must be between the ages of 18 to 99 years.
  • The patient should not have any systemic diseases.
  • There must be a toothless area in either the mandibular or maxillary region.
  • There must be natural teeth present in the opposing arch.
  • The patient should be periodontally healthy.
  • There should not be any oral or mucosal diseases present.
  • There must be sufficient bone present for implant placement, with a diameter of at least 3.5 mm and a height of 8 mm.

You may not qualify if:

  • Please find below a list of factors that may affect dental treatment and require special consideration:
  • Patients who fall outside the specified age range.
  • Patients with systemic diseases.
  • Patients who have received radiotherapy to the head and neck region.
  • Patients who have bruxism habits.
  • Patients who smoke more than 10 cigarettes per day.
  • Patients who use drugs that suppress the immune system or impair healing, such as steroids or bisphosphonates.
  • Patients with alcohol and substance addiction.
  • Patients who do not comply with treatment.
  • Pregnant women and those who are breastfeeding.
  • Mentally retarded patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kütahya Health Sciences University Faculty of Dentistry, Department of Periodontology

Kütahya, 43100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Peri-Implantitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Berceste Guler Ayyildiz

    Kutahya Health Science University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: randomized, controlled, prospective
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assoc.prof.dr.

Study Record Dates

First Submitted

July 15, 2024

First Posted

July 18, 2024

Study Start

April 5, 2023

Primary Completion

September 5, 2025

Study Completion

September 5, 2025

Last Updated

December 2, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share

If contacted, the principal researcher's evaluation will be shared.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
6 months after the study is completed and published
Access Criteria
If contacted, the principal researcher's evaluation will be shared.

Locations